MedPath

EMA Approvals

European Medicines Agency approved drug marketing authorisations and regulatory information

European Medicines Agency
European Union
1,960 Approvals
Showing 321 to 340 of 1,960 approvalsPage 17 of 98

Nexviadyme

Authorisation: Jun 24, 2022

Xenpozyme

Authorisation: Jun 24, 2022

Filsuvez

Authorisation: Jun 21, 2022

Tabrecta

Authorisation: Jun 20, 2022

Tabrecta

Authorisation: Jun 20, 2022

Yselty

Authorisation: Jun 14, 2022

Dovato

Authorisation: Jun 10, 2022

Lunsumio

Authorisation: Jun 3, 2022

Carvykti

Authorisation: May 25, 2022

Carvykti

Authorisation: May 25, 2022

Carvykti

Authorisation: May 25, 2022

Carvykti

Authorisation: May 25, 2022

Camcevi

Authorisation: May 24, 2022

Amifampridine SERB

Authorisation: May 19, 2022

Amversio

Authorisation: May 5, 2022

Orgovyx

Authorisation: Apr 29, 2022

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.